Home / Medical devices / ALLEGRA Transcatheter Aortic Valve Imp-ion System

ALLEGRA Transcatheter Aortic Valve Imp-ion System

Max. value paid with public resources: Processing

Data for med. device
07IIIC6024552492
GTIN
426050866XXXX
15/09/2021 16:56
05/08/2022 11:05
03/09/2021 10:03
Identification of the manufacturer
NVT GmbH
EGN
5709216778
DE
Hechingen
72379
Lotzenäcker 17
Holger Sigg
+49 (0) 7471-98979-0
+49 (0) 7471-98979-222
regulatory@nvt-med.com
Identification of the person placing the product on the market
Marimpex-7 Ltd
EIK
130489377
BG
SOF
Sofia
1612
bul.Tzar Boris III N 54
Adriana Bozhkova
02 9532561
02 9595821
office@marimpex7.bg
Identification of the wholesaler
Marimpex-7 Ltd
EIK
130489377
BG
SOF
Sofia
1612
bul.Tzar Boris III N 54
Adriana Bozhkova
02 9532561
02 9595821
office@marimpex7.bg
IV-Р-Т/МИ-186
11/12/2007
General medical information about the device
07 - Non-active implantable devices
Class ІІІ
Cardiovascular system
GMDN
60245
Aortic Transcatheter heart valve
ALLEGRA Transcatheter Aortic Valve Imp-ion System
Description of the medical device
1
Sterility, Hospital prescription
bovine pericardium
Intended action by the manufacturer
The ALLEGRA Transcatheter Aortic Valve Implantation System TF is indicated for the treatment of severe calcified aortic valve stenosis in high risk patients with elevated surgical risk or in patients with a symptomatic degeneration of an aortic valve bioprosthesis.
Single use
THV-AO00XXG1RE
General trade information
Processing
51380-61-A0
28/07/2027